Share this article Eisai’s Leqembi 100mg IV injection is approved to treat patients with early Alzheimer’s disease. Credits: joshimerbin/Shutterstock.com As Eli Lilly’s plans for its
New study released by the Lancet shows that, in 2022, more than 1 billion people in the world are now living with obesity.
Campaigns in Africa to stop polio and other diseases have a more stable, better-motivated workforce thanks to WHO’s collaboration with countries and partners to pay
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone
New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that
Share this article According to GlobalData’s company profile on Novartis, Cancer treatment biomarkers was a key innovation area identified from patents. Novartis‘s grant share as
Share this article According to GlobalData’s company profile on A. Menarini Industrie Farmaceutiche Riunite, Cancer treatment biomarkers was a key innovation area identified from patents.
Share this article According to GlobalData’s company profile on Yuhan, Cancer treatment biomarkers was a key innovation area identified from patents. Yuhan‘s grant share as
Share this article According to GlobalData’s company profile on Lonza Group, Nanoemulsion cosmetics was a key innovation area identified from patents. Lonza Group‘s grant share